Long-term response of pituitary carcinoma to temozolomide. Report of two cases.
about
Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas with Adjuvant Temozolomide Chemotherapy: A ReviewThe Treatment of Cushing's Disease.Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O(6)-methylguanine methyltransferase (MGMT) promoter methylation and expressionTreatment of pituitary carcinomas and atypical pituitary adenomas: a reviewTemozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center.The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of pituitary adenomas: a study of 197 cases and indications for the medical therapyTemozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina.Clinical review: Pituitary carcinoma: difficult diagnosis and treatmentNelson's Syndrome.ACTH-producing carcinoma of the pituitary with refractory Cushing's Disease and hepatic metastases: a case report and review of the literatureMultimodality treatment for invasive pituitary adenomas.A Rapid Biochemical and Radiological Response to the Concomitant Therapy with Temozolomide and Radiotherapy in an Aggressive ACTH Pituitary Adenoma.Treatment of pituitary neoplasms with temozolomide: a review.Therapy of aggressive pituitary tumors.Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status.Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature.Temozolomide in the management of dopamine agonist-resistant prolactinomas.Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment.Temozolomide in aggressive pituitary adenomas and carcinomas.Macroprolactinoma: a diagnostic and therapeutic update.Orbital metastasis of pituitary growth hormone secreting carcinoma causing lateral gaze palsy.Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide.Molecular basis of pharmacological therapy in Cushing's disease.Emerging drugs for acromegaly.Temozolomide-Induced Shrinkage of Invasive Pituitary Adenoma in Patient with Nelson's Syndrome: A Case Report and Review of the Literature.Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas.The safety of treatments for prolactinomas.Temozolomide treatment of pituitary carcinomas and atypical adenomas: systematic review of case reportsRadiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma.O-methylguanine-DNA methyltransferase immunoexpression in a double pituitary adenoma: case report.Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor.A case of nonfunctioning pituitary carcinoma that responded to temozolomide treatment.Temozolomide therapy: Focus on patients with pituitary carcinoma.A history of pituitary pathology.MGMT immunoexpression in adamantinomatous craniopharyngiomas.Aggressive and malignant prolactin pituitary tumors: pathological diagnosis and patient management.Treatment of aggressive prolactinoma with temozolomide: A case report and review of literature up to date.Expression of O⁶-methylguanine DNA methyltransferase (MGMT) and immunohistochemical analysis of 12 pineal parenchymal tumors.Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma).Temozolomide and Pituitary Tumors: Current Understanding, Unresolved Issues, and Future Directions.
P2860
Q26739267-4CD8EE6A-4DCC-4015-A94C-38024CD8148BQ27010590-000A0F38-F00F-4741-8257-104F1F7F5689Q30353110-C07DBBED-7E34-4E2A-8397-EFF5B7B19FF8Q30872897-6BE50BFA-D1C9-41E5-9CA0-4B17F8A11242Q33419582-69BB796A-0AE0-4954-A4CA-B03F0F7A3548Q34467881-3F178668-3837-4028-8383-0D1F317BB517Q35708559-C96EA692-6269-4D82-AAF8-000A013F9BDFQ35750569-88C66B22-1E03-4563-B48C-A711D69D4867Q37062085-28EA020C-0096-4CA6-A4C5-03A866C1C846Q37182183-4DFEBB9B-DB2A-4BD5-944F-3E7D6600503BQ37427263-94DB8D17-9F7B-49D7-BCDA-3886A916EDF7Q37710210-DA1FADFB-C89F-4DEE-A98F-6A07FD801087Q37789267-5BC5CF89-7453-45AF-B4D5-67F4A501950BQ37857296-C56BFDAB-39FC-4E4B-B682-F24861C18B2FQ37865580-C4B5995B-2A6A-4913-9D6F-73B4749C04A2Q37955091-7C8B26BF-4F3F-4B8D-AC95-EA47DA51DB79Q37988909-9E02597C-E8F8-4F65-B67A-580D58C943EFQ37992191-A9B60F38-BB25-4314-8017-7CA71C5B3675Q38010032-9944AB87-C9D0-4E02-A768-E8765F671411Q38074909-C601CB27-6DB2-46C5-9CB7-67C52B052EE1Q38104350-DBA6ED9E-BD98-4FF2-98DF-2F1167E92496Q38129776-7FD5492E-1C28-4BBB-AD4C-9D9795DD46E9Q38165863-E192DD12-0A67-4479-87C3-5C3A1D966388Q38176659-55D35718-913D-4263-A522-A56D71411CFBQ38556703-07572AAC-438B-4527-8814-3526A01A7329Q38650974-4E09C957-E471-43FD-AC25-B43361E97E9CQ38726058-8F80E657-B979-4979-9E24-6A38445351E5Q38934576-A76624A1-57C6-4EFA-9AA5-361C1C5A3BEBQ39829276-E74CE88F-820F-44BA-AE01-71B389981AD1Q39908548-B07E6555-946A-4ACA-8FF2-4F0FDF9F09A3Q41429257-497DE546-3763-4616-BCDB-DA9CD507DE98Q42002190-8827CF30-A815-4811-9E9B-8FDE620F566EQ42268495-C04E2CD5-42B5-4E67-9ADA-769223886B94Q42450649-A874CC30-8A47-4769-962F-E76EC0CD9486Q44751918-4E41AA28-D75D-43B9-AE61-304234CC851CQ46316098-6AD5B204-9FBE-4046-9E6A-8AE279B62F6CQ47115174-7591EDB1-01F2-478D-ADD8-D6DF1BECC641Q48592886-E408EEAE-E588-4BEC-A737-D6320F56A0B3Q49330862-3930FDAD-8F56-41B6-BFE4-BC8BF7A344CEQ55370601-CFA33FFA-2175-4AF7-8594-75758930CA13
P2860
Long-term response of pituitary carcinoma to temozolomide. Report of two cases.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Long-term response of pituitary carcinoma to temozolomide. Report of two cases.
@en
Long-term response of pituitary carcinoma to temozolomide. Report of two cases.
@nl
type
label
Long-term response of pituitary carcinoma to temozolomide. Report of two cases.
@en
Long-term response of pituitary carcinoma to temozolomide. Report of two cases.
@nl
prefLabel
Long-term response of pituitary carcinoma to temozolomide. Report of two cases.
@en
Long-term response of pituitary carcinoma to temozolomide. Report of two cases.
@nl
P2093
P1476
Long-term response of pituitary carcinoma to temozolomide. Report of two cases.
@en
P2093
Andrew L Kominsky
C Harker Rhodes
Camilo E Fadul
Clifford J Eskey
Linda S Kingman
Louise P Meyer
Nathan E Simmons
William B Kinlaw
P304
P356
10.3171/JNS.2006.105.4.621
P407
P577
2006-10-01T00:00:00Z